AKT1 and acute myeloid leukemia: Flow cytometric analysis confirmed a decrease in canonical oncogenic Ras effector signaling pathways—MAPK and PI3K—with decreased levels of phosphorylated ERK and AKT following Dox-mediated suppression of NRAS(V12) in both de novo NRD and relapsed NRI AML cells (Figure 3a).